Brand Manager
About the job
- A bachelor's degree or equivalent is required.
- Relevant experience with a proven track record of success in marketing within the biotech or pharmaceutical industry across multiple brands and team constellations is required.
- Hemato-oncology experience is a strong advantage.
- The role requires the ability to translate strategies into actionable and realistic marketing actions.
- The role requires the ability to lead, motivate, and coordinate cross-functional teams.
- A proven track record of successful leadership, management, and coaching of teams and individuals, including talent development and performance management of low performers, is required.
- Solid working knowledge of the healthcare environment and its evolving landscape is required.
- Solid knowledge of strategic and tactical marketing principles and techniques, including digital marketing, is required.
- Solid knowledge of finance principles and processes is required.
- English proficiency, verbally and in writing, is required in non-English-speaking countries.
- Lead the comprehension of patient experience insights across the Brand and In-Field teams and develop the Patient Journey to focus the Brand Team on patient-centric strategies, including Close Loop Marketing engagement and customization, in accordance with the business code of conduct, policies, and applicable laws and regulations.
- Collaborate with Brand Team and In-Field Team members; facilitate discussions across stakeholders, including healthcare professional and non-healthcare professional stakeholders; synthesize insights to identify target segments, determine brand positioning, drive Close Loop Marketing engagement and customization, and populate the Brand Plan Insights Chapter.
- Secure input and cross-stakeholder viewpoints to develop an accurate Patient Journey; propose strategic objectives for Brand Team review based on Patient Journey findings; and challenge and critique Brand Team strategies to ensure patient-centricity.
- Ensure all functional deliverables are consistent with branding and deliver emotional messages aligned with the Brand Story.
- Guide the design and implementation of marketing activities, incorporating innovative marketing tactics, traditional and non-traditional partnerships, multichannel opportunities, and multistakeholder initiatives to meet strategic brand objectives.
- Ensure all in-field materials, strategies, and tactics are aligned to drive momentum toward strategic brand objectives.
- Lead development of marketing inputs to the Strategic Brand Plan, consolidate the one-year Tactical Brand Plan, and coordinate preparation of the Long Range Plan to drive brand success.
- Develop, lead, and coach direct reports, if applicable; forecast and monitor brand key performance indicators; manage the budget and brand profit and loss, if applicable; and track return-on-investment measurements for marketing activities to achieve or exceed brand plan objectives.
- Hemato-oncology experience is a strong advantage.
About the company
AbbVie is a global biopharmaceutical company that develops and sells medicines to treat serious health conditions. Its portfolio spans immunology, oncology, virology, neuroscience, and aesthetics, with products designed to modulate the immune system, target disease pathways, or support medical aesthetics. AbbVie compounds its products through a heavy emphasis on research and development, investing billions to build a steady pipeline of new therapies. Its medicines are brought to market by selling to healthcare providers, hospitals, and clinics, and in some cases directly to patients via prescriptions. The company differentiates itself through a wide, globally distributed product line, substantial R&D investment, and a commitment to sustainability and patient care, including science-based targets. AbbVie’s goal is to improve patient outcomes by delivering effective treatments for unmet medical needs while pursuing long-term, responsible growth across healthcare markets.
Company Size
10,001+
Company Stage
IPO
Headquarters
North Chicago, Illinois
Founded
1888
Get referred to AbbVie
See people who can refer or advise you
Simplify's Take
What believers are saying
- Apogee acquisition closed in 2026, expanding AbbVie’s immunology pipeline beyond Skyrizi and Rinvoq.
- EU approvals for RINVOQ and EPKINLY in September 2026 broaden ex-U.S. revenue.
- JUVMO launches in October 2026, adding a fresh neuroscience revenue line.
What critics are saying
- Humira, Skyrizi, and Rinvoq concentration keeps AbbVie exposed if immunology growth slows in 2027.
- Niaspan antitrust MDL and Biocell ALCL settlements carried $1.7 billion litigation accrual by June 2026.
- Generic ubrogepant and atogepant suits threaten Ubrelvy and Qulipta exclusivity within years.
What makes AbbVie unique
- Skyrizi and Rinvoq anchor AbbVie’s post-Humira immunology franchise across 11 EU RINVOQ indications.
- JUVMO’s September 28, 2026 FDA approval gives AbbVie first-in-class Parkinson’s D1/D5 therapy.
- AbbVie pairs blockbuster cash flows with Apogee, Iambic, and Valkai deal-making.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Remote Work Options
- Flexible Work Hours
- Professional Development Budget